Found vs altRx: Personalized biology plans vs lowest-price GLP-1 offers
Comparing Found vs altRx: quick verdict — Found emphasizes a biology-first, personalized medically supervised program with insurance acceptance and plans starting at as low as $39, while altRx emphasizes being the most affordable GLP-1 program with compounded semaglutide from $89/month and tirzepatide from $149/month.
Explore Found’s biology-first plans starting at $39
How they differ: personalization, pricing, and insurance
Found vs altRx diverge most on personalization and insurance, pricing structure, and visit delivery. Found offers a biology-based personalized program that targets hormones, metabolism, sleep, and behavior. Found advertises personalized medically supervised weight loss programs and accepts most insurance, noting “Get started for as low as $39” and that “Most insurance now accepted.”
Personalization and program focus
Found builds individualized plans around metabolic biology rather than prescribing a single medication protocol for all patients. altRx provides a personalized care plan if a provider determines treatment is appropriate, but its core message centers on affordable access to compounded GLP-1s and a fast online start.
Start altRx’s online quiz for $89/month semaglutide
Pricing and medication options
Price positioning is a key difference. Found markets “starting at $39” and highlights affordable monthly plans, membership pricing, and insurance-handling for branded GLP-1s in some programs. altRx promotes a limited offer: compounded semaglutide at $89/month and tirzepatide at $149/month, with multi-month discounts noted in altRx FAQ details.
| Criteria | Found | altRx |
|---|---|---|
| Starting price | Get started for as low as $39 | Semaglutide $89/mo · Tirzepatide $149/mo |
| Program focus | Biology-first personalized medically supervised program | Most affordable GLP-1 program, online-first |
| Insurance | Most insurance now accepted; Found handles insurance paperwork | No insurance required; direct-pay model |
| Medication types | Branded and compounded GLP-1s; tirzepatide; compounded options | Compounded semaglutide and compounded tirzepatide |
| Visit model | Medical evaluation and supervised program (telehealth) | 100% online medical visits; telehealth review |
| Availability and regulatory note | Compounded GLP-1s are not FDA-approved; not available in all states | Compounded medications not FDA-approved; membership available in all 50 states |
Delivery, membership, and cancellation differences
altRx emphasizes 100% online visits, free discreet 2-day delivery, no membership or hidden fees, and “cancel anytime” with same price every month. Found emphasizes affordable monthly plans, cancel anytime in some plans, and handling insurance paperwork; Found also presents membership tiers and some quoted monthly membership starting points.
See Found membership and insurance options
Regulatory and medication notes to consider
Both providers offer compounded GLP-1 options and include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Found explicitly notes that compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy and may not be available in all states. altRx likewise states compounded medication is not FDA-approved and notes provider availability and prescribing authority vary by state.
Which provider fits which situation: Found vs altRx
Found is positioned for people who want weight loss built around their biology and who may benefit from insurance handling and a medically supervised, personalized approach. altRx is built for patients focused on lowest advertised prices and fully online, quick-start access to compounded GLP-1s with clear monthly pricing such as semaglutide at $89/mo and tirzepatide at $149/mo.
Claim altRx’s limited offer pricing and start online
Compare Found plans and begin a biology-first evaluation
Final thoughts on Found vs altRx
For a quick summary using the primary keyword: Found vs altRx contrasts a biology-first, insurance-friendly, personalized program starting at as low as $39 with altRx’s limited-offer, lowest-price, fully online compounded GLP-1 plans starting at $89/month for semaglutide and $149/month for tirzepatide. Both note compounded medications are not FDA-approved.
Choose Found if you want a biology-based, medically supervised program and the possibility of using insurance for GLP-1 access.
Choose altRx if your priority is the lowest advertised monthly price for compounded GLP-1s and a 100% online, no-insurance-required experience.